These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
235 related items for PubMed ID: 19584708
1. The antipsychotic drug chlorpromazine enhances the cytotoxic effect of tamoxifen in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells. Yde CW, Clausen MP, Bennetzen MV, Lykkesfeldt AE, Mouritsen OG, Guerra B. Anticancer Drugs; 2009 Sep; 20(8):723-35. PubMed ID: 19584708 [Abstract] [Full Text] [Related]
2. Protein Kinase C alpha is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells. Frankel LB, Lykkesfeldt AE, Hansen JB, Stenvang J. Breast Cancer Res Treat; 2007 Aug; 104(2):165-79. PubMed ID: 17061041 [Abstract] [Full Text] [Related]
3. Cyclin D1 expression is dependent on estrogen receptor function in tamoxifen-resistant breast cancer cells. Kilker RL, Hartl MW, Rutherford TM, Planas-Silva MD. J Steroid Biochem Mol Biol; 2004 Sep; 92(1-2):63-71. PubMed ID: 15544931 [Abstract] [Full Text] [Related]
4. Drug and hormone sensitivity of estrogen receptor-positive and -negative human breast cancer cells in vitro. Goldenberg GJ, Froese EK. Cancer Res; 1982 Dec; 42(12):5147-51. PubMed ID: 7139616 [Abstract] [Full Text] [Related]
5. An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells. Aesoy R, Sanchez BC, Norum JH, Lewensohn R, Viktorsson K, Linderholm B. Mol Cancer Res; 2008 Oct; 6(10):1630-8. PubMed ID: 18922978 [Abstract] [Full Text] [Related]
6. Modulation of epirubicin cytotoxicity by tamoxifen in human breast cancer cell lines. Azab SS, El-Demerdash E, Abdel-Naim AB, Youssef E, El-Sharkawy N, Osman AM. Biochem Pharmacol; 2005 Sep 01; 70(5):725-32. PubMed ID: 16005435 [Abstract] [Full Text] [Related]
11. Activation of mitogenic pathways and sensitization to estrogen-induced apoptosis: two independent characteristics of tamoxifen-resistant breast cancer cells? Scherbakov AM, Lobanova YS, Shatskaya VA, Onopchenko OV, Gershtein ES, Krasil'nikov MA. Breast Cancer Res Treat; 2006 Nov 01; 100(1):1-11. PubMed ID: 16990991 [Abstract] [Full Text] [Related]
17. Tamoxifen stimulates the growth of cyclin D1-overexpressing breast cancer cells by promoting the activation of signal transducer and activator of transcription 3. Ishii Y, Waxman S, Germain D. Cancer Res; 2008 Feb 01; 68(3):852-60. PubMed ID: 18245487 [Abstract] [Full Text] [Related]
18. Clusterin: a potential target for improving response to antiestrogens. Toffanin S, Daidone MG, Miodini P, De Cecco L, Gandellini P, Cappelletti V. Int J Oncol; 2008 Oct 01; 33(4):791-8. PubMed ID: 18813793 [Abstract] [Full Text] [Related]
19. Synergistic cytotoxic effects of tamoxifen and black cohosh on MCF-7 and MDA-MB-231 human breast cancer cells: an in vitro study. Al-Akoum M, Dodin S, Akoum A. Can J Physiol Pharmacol; 2007 Nov 01; 85(11):1153-9. PubMed ID: 18066117 [Abstract] [Full Text] [Related]
20. Tamoxifen-induced enhancement of calcium signaling in glioma and MCF-7 breast cancer cells. Zhang W, Couldwell WT, Song H, Takano T, Lin JH, Nedergaard M. Cancer Res; 2000 Oct 01; 60(19):5395-400. PubMed ID: 11034078 [Abstract] [Full Text] [Related] Page: [Next] [New Search]